scispace - formally typeset
Journal ArticleDOI

Pramlintide in the treatment of type 1 and type 2 diabetes mellitus

Gina J. Ryan, +2 more
- 01 Oct 2005 - 
- Vol. 27, Iss: 10, pp 1500-1512
Reads0
Chats0
TLDR
Use of pramlintide in addition to insulin in patients with type 1 and type 2 diabetes was associated with modest reductions in HbA(1c) and the incidence of hypoglycemia in the first 4 weeks of therapy was 2 to 4 times greater with pramsintide compared with placebo; thus, the manufacturer recommends reducing the dose of premeal insulin by 50% when starting pramlintide.
About
This article is published in Clinical Therapeutics.The article was published on 2005-10-01. It has received 133 citations till now. The article focuses on the topics: Pramlintide & Type 1 diabetes.

read more

Citations
More filters
Book

Type 2 Diabetes in Children and Adolescents

TL;DR: This study presents a novel and scalable approach called “informed consent” that aims to provide real-time information about the risks and benefits of vaccination in relation toocrinology andocrinology-related illnesses.
Journal ArticleDOI

Gastric emptying and glycaemia in health and diabetes mellitus

TL;DR: Gastric emptying accounts for ∼35% of the variance in peak postprandial blood glucose concentrations in healthy individuals and in patients with diabetes mellitus, and the rate of emptying is itself modulated by acute changes in glycaemia, so clinical implementation of incretin-based therapies for the management of T2DM, in part by slowing gastric empties, is widespread.
Journal ArticleDOI

Renal glucose reabsorption inhibitors to treat diabetes

TL;DR: In T2DM, the glucosuria produced by SGLT2 inhibitors is associated with weight loss, and mild osmotic diuresis might assist a reduction in blood pressure, and the mechanism is independent of insulin and carries a low risk of hypoglycaemia.
Journal ArticleDOI

ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent

TL;DR: This poster presents a poster presented at the 2016 American Academy of Pediatrics annual meeting entitled “Advances in Pediatric Endocrinology and Metabolism: Foundations of Natural Selection for Adolescent Health, 2nd Ed.”

ISPAD Clinical Practice Consensus Guidelines 2009 Compendium

TL;DR: This article is a chapter in the ISPAD Clinical Practice Consensus Guide-lines 2009 Compendium, entitled “Children’s Hospital at Westmead, NSW, Australia: Advances in Paediatrics and Paediatric Endocrinology and Diabetes since the Guidelines were published in 2009.
References
More filters
Journal ArticleDOI

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

TL;DR: Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Journal Article

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 - 
TL;DR: In this article, the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
Journal Article

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

TL;DR: Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight diabetic patients, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in these patients.
Journal ArticleDOI

Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes

TL;DR: Participants with previously diagnosed diabetes in NHANES 1999-2000 were similar by age and sex, were less likely to be non-Hispanic white, were diagnosed at an earlier age, had a higher body mass index, and were more likely to use insulin in combination with oral agents.
Journal ArticleDOI

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

TL;DR: A peptide, of calculated molecular mass 3905 Da, that was a major protein component of amyloid-rich pancreatic extracts of three type 2 diabetic patients is described, indicating that these peptides are related in evolution.
Related Papers (5)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 -